Type:
Educational Exhibit
Keywords:
Lymph nodes, Breast, Oncology, CT, Ultrasound, PET-CT, Diagnostic procedure, Prostheses, Cancer, Haematologic diseases
Authors:
E. Pace, A. Wotherspoon, A. Attygalle, S. Iyengar, B. sharma; London/UK
DOI:
10.1594/ecr2018/C-3245
Conclusion
Breast implant-associated anaplastic large T-cell lymphoma is a rare disease,
relatively recently increasingly recognised,
not well known or understood by clinicians,
radiologists or most lymphoma specialists not having experience of this condition.
Establishing its diagnosis is often challenging.
It is crucial to identify the potential for this condition when a patient with breast implant presents with late onset seroma,
and for a breast radiologist to perform a diagnostic aspirate which is cytologically analysed for lymphoma cells.
BI-ALCL presenting with seroma only has a good prognosis,
surgical management being curative.
Mass-forming BI-ALCL has poor outcomes,
and requires systemic chemotherapy treatment.
We suggest that surveillance imaging (CT,
PET,
MRI) should not routinely be performed in BI-ALCL patients: seroma only patients having a good prognosis; clinical follow up being appropriate in mass-forming disease,
in line with other lymphomas.